These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34715068)

  • 41. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits.
    Urios A; Mangas-Losada A; Gimenez-Garzó C; González-López O; Giner-Durán R; Serra MA; Noe E; Felipo V; Montoliu C
    Liver Int; 2017 Jul; 37(7):1013-1022. PubMed ID: 27988985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology, diagnosis, and management of hepatic encephalopathy.
    Sheasgreen C; Lu L; Patel A
    Inflammopharmacology; 2014 Dec; 22(6):319-26. PubMed ID: 25300964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited.
    Butterworth RF
    Metab Brain Dis; 2016 Dec; 31(6):1211-1215. PubMed ID: 26521983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis.
    Lachar J; Bajaj JS
    Semin Liver Dis; 2016 Sep; 36(4):327-330. PubMed ID: 27997972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.
    Luo M; Guo JY; Cao WK
    World J Gastroenterol; 2015 Nov; 21(41):11815-24. PubMed ID: 26557005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for oxidative/nitrosative stress in the pathogenesis of hepatic encephalopathy.
    Bemeur C; Desjardins P; Butterworth RF
    Metab Brain Dis; 2010 Mar; 25(1):3-9. PubMed ID: 20195724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Liver cirrhosis as a multisystem disease].
    Bettinger D; Thimme R; Schultheiß M
    Dtsch Med Wochenschr; 2024 Jun; 149(12):690-695. PubMed ID: 38781992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut-derived systemic inflammation as a driver of depression in chronic liver disease.
    Kronsten VT; Tranah TH; Pariante C; Shawcross DL
    J Hepatol; 2022 Mar; 76(3):665-680. PubMed ID: 34800610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic encephalopathy is linked to alterations of autophagic flux in astrocytes.
    Lu K; Zimmermann M; Görg B; Bidmon HJ; Biermann B; Klöcker N; Häussinger D; Reichert AS
    EBioMedicine; 2019 Oct; 48():539-553. PubMed ID: 31648987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy.
    Bosoi CR; Rose CF
    Metab Brain Dis; 2013 Jun; 28(2):175-8. PubMed ID: 23124921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis.
    Arroyo V; Angeli P; Moreau R; Jalan R; Clària J; Trebicka J; Fernández J; Gustot T; Caraceni P; Bernardi M;
    J Hepatol; 2021 Mar; 74(3):670-685. PubMed ID: 33301825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic encephalopathy: a critical current review.
    Hadjihambi A; Arias N; Sheikh M; Jalan R
    Hepatol Int; 2018 Feb; 12(Suppl 1):135-147. PubMed ID: 28770516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiology of Hepatic Encephalopathy.
    Jaffe A; Lim JK; Jakab SS
    Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current concepts in the assessment and treatment of hepatic encephalopathy.
    Cash WJ; McConville P; McDermott E; McCormick PA; Callender ME; McDougall NI
    QJM; 2010 Jan; 103(1):9-16. PubMed ID: 19903725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammation and hepatic encephalopathy.
    Coltart I; Tranah TH; Shawcross DL
    Arch Biochem Biophys; 2013 Aug; 536(2):189-96. PubMed ID: 23583306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Positron emission tomography (PET) before and after treatment of hyperammonemia in a patient with decompensated liver cirrhosis].
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Murai K; Sadoshima S; Fujishima M; Ichiya Y
    Fukuoka Igaku Zasshi; 1991 Oct; 82(10):521-7. PubMed ID: 1748367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention and treatment of hepatic encephalopathy].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis.
    Bersagliere A; Raduazzo ID; Schiff S; Gatta A; Merkel C; Amodio P; Achermann P; Montagnese S
    Clin Neurophysiol; 2013 Mar; 124(3):492-6. PubMed ID: 22999317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ornithine phenylacetate revisited.
    Jover-Cobos M; Noiret L; Sharifi Y; Jalan R
    Metab Brain Dis; 2013 Jun; 28(2):327-31. PubMed ID: 23456516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment.
    Montagnese S; Gordon HM; Jackson C; Smith J; Tognella P; Jethwa N; Sherratt RM; Morgan MY
    Hepatology; 2005 Oct; 42(4):772-81. PubMed ID: 16175619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.